HRTX SC13G

Company

HERON THERAPEUTICS, INC. /DE/

Filed

February 16, 2016

Accession Number

0001086318-16-000066

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →